Abingworth
Organization · Investor
Minutes holds 3 deals naming Abingworth.
Deals in Minutes
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| Iambic TherapeuticsBiotech | Funding | At least $100M | Investors Abingworth, Alexandria Venture Investments +14 | 10 Nov 2025 | Closed |
| Iambic TherapeuticsBiotech | FundingSeries B extension | $50M | Led by Mubadala Capital, Exor VenturesWith Qatar Investment Authority, Abingworth +4 | 18 Jun 2024 | Closed |
| Iambic TherapeuticsBiotech | FundingSeries B | $100M | Led by Ascenta Capital, AbingworthWith NVIDIA, Illumina Ventures +9 | 3 Oct 2023 | Closed |
- FundingSeries B extension, led by Mubadala Capital +7Biotech · 18 Jun 2024 · Closed
Investments
- 3
- 1
- 1
- 1
By stage
- Series B1
- Series B extension1
- Stage not recorded1
By industry
- Healthcare3
- Technology3
By region
- Region not recorded3
Deals Minutes has recorded
| Date | Company | Round | Amount | Role | Outcome |
|---|---|---|---|---|---|
| 10 November 2025 | Iambic Therapeutics | Funding round | at least $100M | Joined | Listed · Oct 2026 |
| 18 June 2024 | Iambic Therapeutics | Series B extension | $50M | Joined | Listed · Oct 2026 |
| 3 October 2023 | Iambic Therapeutics | Series B | $100M | Led | Listed · Oct 2026 |
Exits
Returns not shown: Minutes does not hold stake sizes unless a party discloses them.
Co-investors in these rounds
Abingworth
No developments name Abingworth yet.